Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Sun Pharma bags rights to $3.7 billion cholesterol drug market globally

Sun Pharma will commercialise and manufacture LIB Therapeutics' once-monthly cholesterol drug outside the US and China after its EU approval

Sun Pharma bags rights to $3.7 billion cholesterol drug market globally

We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.

Read the original at business-standard.com →

More in Health & Medicine

More from Monday 28 September →